missing translation for 'onlineSavingsMsg'
Learn More
Learn More
BD Biosciences™ Anti-Human Lineage Cocktail 3 (lin 3) (CD3, CD14, CD19, CD20) (RUO/GMP)
Description
- Clone SK7 (also known as Leu-4) L27 SJ25C1 (also known as SJ25-C1) MφP9 (also known as MφP-9) (RUO (GMP))
- Mouse IgG1 heavy chains and kappa light chains:
- CD3, clone SK7
- CD19, clone SJ25C1
- CD20, clone L27
- Mouse IgG2b heavy chains and kappa light chains:
- CD14, clone MφP9
- The Lineage Cocktail3 (lin 3) contains antibody clones that, in combination, stain lymphocytes, monocytes, eosinophils, and neutrophils.
- It includes CD3, CD14, CD19, and CD20. Peripheral blood dendritic cells (DCs), including those expressing CD16, can be distinguished from other leucocytes by their lack of staining with lin 3.
- Contents:
- Specificity: CD14:, Clone: MφP9 (MφP-9), Format FITC, Isotype: IgG2bK
- Specificity: CD3, Clone: SK7(Leu-4), Format: FITC, Isotype: IgG1K, Entrez Gen ID: 916
- Specificity: CD19, Clone: SJ25C1 (SJ25-C1), Format: FITC, Isotype: IgG1K, Entrez Gen ID: 930
- Specificity: CD20, Clone: L27, Format: FITC, Isotype: IgG1K, Entrez Gen ID: 931
- Research applications include the following:
- Dendritic cells (DC) in peripheral blood.
Specifications
Specifications
| Antigen | CD3, CD20, CD19, CD14 |
| Applications | Flow Cytometry |
| Clone | SK7, L27, SJ25C1, MφP9 |
| Concentration | 37.6 μg/mL |
| Host Species | Mouse |
| Quantity | 50 Tests |
| Regulatory Status | RUO |
| Includes | Phosphate buffered saline with gelatin and 0.1% sodium azide. |
| Target Species | Human |
| Content And Storage | Store vials at 2°C–8°C. Conjugated forms should not be frozen. Protect from exposure to light. Each reagent is stable until the expiration date shown on the bottle label when stored as directed. |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?